Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES (ABT)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales20 40520 85327 39031 07332 93434 967
EBITDA4 8504 9757 0227 6678 4449 567
Operating profit (EBIT)3 9794 1725 9766 5967 0768 080
Pre-Tax Profit (EBT)------
Net income4 4231 4004772 5363 2483 415
P/E ratio15,440,921147,833,930,4
EPS ( $ )2,920,940,271,301,842,05
Dividend per Share ( $ )0,981,041,061,111,201,30
Yield2,18%2,71%1,86%1,79%1,92%2,08%
Reference price ( $ )44.9138.4157.0762.3462.3462.34
Announcement Date01/28/2016
12:31pm
01/25/2017
12:45pm
01/24/2018
12:45pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt2 8763 23118 31415 25813 0379 416
Finance------
Operating income (EBITDA)4 8504 9757 0227 6678 4449 567
Leverage
(Debt/EBITDA)
0,59x0,65x2,61x1,99x1,54x0,98x
Capital Expenditure1 1101 1211 1351 2271 2761 189
Book Value Per Share (BVPS)14,4 $13,9 $17,7 $18,1 $19,0 $20,3 $
Cash Flow per Share1,97 $2,16 $3,18 $2,87 $3,50 $3,59 $
Announcement Date01/28/2016
12:31pm
01/25/2017
12:45pm
01/24/2018
12:45pm
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 110 135 M$ -
Entreprise Value (EV) 125 393 M$ 123 172 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS) 47,8x 33,9x
Capitalization / Revenue 3,54x 3,34x
EV / Revenue 4,04x 3,74x
EV / EBITDA 16,4x 14,6x
Yield (DPS / Price) 1,79% 1,92%
Price to book (Price / BVPS) 3,44x 3,28x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 21,2% 21,5%
operating Leverage (Delta EBIT / Delta Sales) 0,77x 1,21x
Net Margin (Net Profit / Revenue) 8,16% 9,86%
ROA (Net Profit / Asset) 5,00% 6,25%
ROE (Net Profit / Equities) 13,9% 15,0%
Rate of Dividend 85,5% 65,3%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   3,95% 3,87%
Cash Flow / Sales 16,2% 18,6%
Capital Intensity (Assets / Sales) 1,63x 1,58x
Financial Leverage (Net Debt / EBITDA) 1,99x 1,54x
EPS & Dividend